Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_assertion type Assertion NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_head.
- NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_assertion description "[By showing that EZH2 expression is associated with increased metastatic potential and a worse clinical outcome, this study suggests that EZH2 can serve as a prognostic biomarker for RCC, thus confirming it as a key molecule driving oncogenesis and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_provenance.
- NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_assertion evidence source_evidence_literature NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_provenance.
- NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_assertion SIO_000772 24079759 NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_provenance.
- NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_assertion wasDerivedFrom befree-20150227 NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_provenance.
- NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_assertion wasGeneratedBy ECO_0000203 NP780406.RAXsxkfN-FPSZJUud4Q18AyrCGVv-DMEe4j2fbXYm9t74130_provenance.